Lv3
388 积分 2024-11-07 加入
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancer
3天前
已完结
Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
3天前
已关闭
Multitarget Inhibition of Histone Deacetylase (HDAC) and Phosphatidylinositol-3-kinase (PI3K): Current and Future Prospects
17天前
已完结
HDAC and PI3K dual inhibitors in the treatment of cancers: Current status, trends, and solutions
17天前
已完结
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo
25天前
已完结
Elucidation of the Role of the Epigenetic Regulatory Mechanisms of PI3K/Akt/mTOR Signaling Pathway in Human Malignancies
25天前
已完结
Targeted based therapy in nodal T-cell lymphomas
26天前
已完结
Nimbolide, a Neem Limonoid, Inhibits Angiogenesis in Breast Cancer by Abrogating Aldose Reductase Mediated IGF-1/PI3K/Akt Signalling
26天前
已完结
Senescence as a therapeutic target in cancer and age-related diseases
1个月前
已完结
Pharmacological modulation of cellular senescence: Implications for breast cancer progression and therapeutic strategies
1个月前
已完结
皖公网安备34019202002308
